Recross Cardio Initiates Groundbreaking PFO Study with First Patient Enrollment Recross Cardio celebrates the enrollment of the first patient in its pioneering PROTEA-PFO study, focusing on innovative stroke prevention technology.

Recross Cardio Initiates Groundbreaking PFO Study with First Patient Enrollment #USA #Boston #Stroke_Prevention #Recross_Cardio #PROTEA-PFO

Studies Suggest Ozempic and Similar Drugs May Reduce Stroke Risk and Associated Brain Injury Impact Recent studies indicate that GLP-1 inhibitors like Ozempic may significantly lower stroke risk and mitigate brain injury. Research highlights promising outcomes linked to these medications.

Studies Suggest Ozempic and Similar Drugs May Reduce Stroke Risk and Associated Brain Injury Impact #United_States #Nashville #Brain_Injury #Ozempic #Stroke_Prevention